Filing Flows › Comparisons › BLND vs CDLX
Blend Labs vs Cardlytics: BLND and CDLX compared
Blend Labs is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $32.9M for Cardlytics (Q3 2026). Blend Labs is growing faster (+0.7% against -30% a year earlier). Blend Labs is more profitable, with an operating margin of -8.0% against -16.5%.
Where the money goes: BLND and CDLX
Blend Labs (BLND) · Q3 2026
Blend Labs, Q3 2026: revenue $32.9M (+0.7% year over year), operating margin -8.0%, net loss $1.9M, operating cash flow $863K. The chart follows the revenue to costs, profit and cash.
Cardlytics (CDLX) · Q3 2026
Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.
| Blend Labs (BLND) | Cardlytics (CDLX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $32.9M | $32.9M |
| Revenue growth, Y/Y | +0.7% | -30% |
| Operating margin | -8.0% | -16.5% |
| Net earnings | −$1.9M | −$8.9M |
| Net margin | -5.9% | -27.2% |
| Operating cash flow | $863K | −$5.9M |
| Free cash flow | $94K | — |
Where the revenue comes from
Blend Labs
- Software platform: $30.6M (93%)
- Professional services: $2.3M (7%)
Cardlytics
- Engagement based pricing: $21.7M (66%)
- Served based pricing: $10.1M (31%)
- Other Revenue(1): $1.1M (3%)
Questions
Which is bigger, Blend Labs or Cardlytics?
Blend Labs is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $32.9M for Cardlytics (Q3 2026).
Is Blend Labs or Cardlytics growing faster?
Blend Labs is growing faster (+0.7% against -30% a year earlier).
Which is more profitable, Blend Labs or Cardlytics?
Blend Labs is more profitable, with an operating margin of -8.0% against -16.5%.
More: Blend Labs earnings · how Blend Labs makes money · Cardlytics earnings · how Cardlytics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.